Company Name NewLink Genetics
Mailing Address 2503 South Loop Drive Ames, IN 50010
Company Description NewLink Genetics (NASDAQ: NLNK) is an emerging biopharmaceutical company focused on discovery and development of novel, immunotherapeutic agents. Our mission is to achieve breakthrough improvements in the survival and quality-of-life of cancer patients. The company has advanced two product platforms into human clinical trials. Its HyperAcute therapeutic vaccines for treatment of pancreatic cancer and lung cancer are progressing in Phase II efficacy studies, and NewLink’s first-in-class, small-molecule inhibitor of the IDO* pathway is undergoing Phase I testing for safety.